Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-02 09:39:53 - browse：66982

Hyacinth Empinado/STAT

The body mass index, or BMI, is the formula that’s used most often to diagnose overweight and obesity. But unlike other common diagnoses, there is a certain stigma applied to people with a high body mass index, or BMI, which can affect how they are perceived by peers, providers, and society at large.

Despite the ubiquity of the BMI in medicine, many argue that it is a flawed tool, with a strange history. In recent months, the BMI has become more relevant than ever as the new semaglutide weight loss drugs are poised to change how obesity is understood and treated.

BMI is a simple calculation — a person’s weight in kilograms divided by the square of their height. But how BMI is then translated into a diagnosis is complicated and flawed.

Related: New weight loss drugs are changing the narrative on obesity, with a push from pharma

Watch this video to learn more about the history of the BMI — how it became so entrenched in medicine and, surprisingly, how its introduction may have set back decades of work on how obesity contributes to disease.

A STAT series is examining new obesity drugs that are transforming patients’ lives, dividing medical experts, and spurring one of the biggest business battles in years. Read more about The Obesity Revolution.

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Abortion clinic in Cancun will cater to Americans

WSS

Diverse clinical trials: Why aren’t we there yet?

What to make of Biden’s latest efforts on cancer research

What to make of Biden’s latest efforts on cancer research

Biotech incubator Curie.Bio graduates its first startup

Removing probiotics from the NICU could threaten preemies' health

How to make the FDA’s new prescription one

explore

Wikipedia

Related: New weight loss drugs are changing the narrative on obesity, with a push from pharma

Wikipedia

DIEP, the 'gold standard' of breast reconstruction, is under threat

Acelyrin, a rare IPO success, stumbles in its first big test

Alkermes shareholders re

White House touts steps to stem shortages of cancer treatments

Medical records are filled with copy

FDA proposes changes to key medical devices approval pathway

After affirmative action ruling, medical educators look to 'holistic review'

MoonLake credibility takes another hit with mid

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Medicare solvency divides Republicans at the presidential debate

leisure time

IRA could hurt research into orphan drugs for rare diseases

New Covid vaccine is recommended for everyone 6 months or older

FDA panel endorses Alnylam’s heart drug — after picking it apart

Regeneron agrees to White House price limits on anti

The new shift in health care is toward less care

WATCH: Why do bright lights make us see spots?

leisure time

explore

hotspot

focus